Pancreatic Cancer Research

ResearcherChina Medical UniversityNo recent work listed

Po‐Chen Chu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-9510-2269; OpenAlex author ID A5045074386. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2017: 1 paper · 2018: 1 paper · 2019: 1 paper

Papers 3

  1. p21-Activated kinase 3 promotes cancer stem cell phenotypes through activating the Akt-GSK3β-β-catenin signaling pathway in pancreatic cancer cells. Last author DOI 10.1016/j.canlet.2019.04.026↗
  2. Targeting integrin-linked kinase to suppress oncogenic KRAS signaling in pancreatic cancer. Co-author DOI 10.1080/21541248.2016.1251383↗
  3. OSU-A9 inhibits pancreatic cancer cell lines by modulating p38-JAK-STAT3 signaling. Co-author DOI 10.18632/oncotarget.16450↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hsing-Yu Wu · 1 shared paper, 2019 · strength 0.12
  2. Li-Yun Ding · 1 shared paper, 2019 · strength 0.12
  3. Tanios Bekaii‐Saab · 1 shared paper, 2018 · strength 0.12
  4. Ching‐Shih Chen · 1 shared paper, 2018 · strength 0.12
  5. Yi-Jin Chen · 1 shared paper, 2017 · strength 0.08
  6. Wan-Chi Tsai · 1 shared paper, 2017 · strength 0.08
  7. Jing‐Ru Weng · 1 shared paper, 2017 · strength 0.08
  8. Li‐Yuan Bai · 1 shared paper, 2017 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.